PNU 99194A

Drug Profile

PNU 99194A

Alternative Names: U 99194A

Latest Information Update: 27 Nov 2001

Price : $50

At a glance

  • Originator Pharmacia Corporation
  • Class Antipsychotics
  • Mechanism of Action Dopamine D3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Schizophrenia

Most Recent Events

  • 27 Nov 2001 Discontinued-Preclinical for Schizophrenia in USA (Unknown route)
  • 28 Jun 1999 Preclinical development for Schizophrenia in USA (Unknown route)
  • 23 Apr 1996 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top